DTP-HepB vaccine

DTP-HepB vaccine is a combination vaccine whose generic name is diphtheria and tetanus toxoids and whole-cell pertussis and hepatitis B (recombinant) vaccine (adsorbed) or DTP-Hep B. It protects against the infectious diseases diphtheria, tetanus, pertussis, and hepatitis B.^[1]

DTP-HepB

Combination of
DTP vaccine	Vaccine
Hepatitis B vaccine	Vaccine
Clinical data
Trade names	Tritanrix-HepB
AHFS/Drugs.com	UK Drug Information
Routes of administration	Intramuscular injection
ATC code	J07CA05 (WHO)
Identifiers
CAS Number	1012056-47-1

A branded formulation, Tritanrix-HepB manufactured by GlaxoSmithKline, was granted marketing approval in the EU in 1996. Marketing approval lapsed in 2014.^[2]

A review conducted in 2012 concluded that there was insufficient evidence to determine differences in safety and efficacy between DTP-HepB vaccine and Hib vaccine administered separately and pentavalent DTP-HepB-Hib vaccine.^[3]